Leap Investments’s Biogen BIIB Stock Holding History

Leap Investments’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,400	Closed	-$326K	–	432
2019 Q3	$326K	Buy	+1,400	New	+$326K	0.16%	215

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Leap Investments's BIIB Position: Q4 2019 in Review

Leap Investments sold out of Biogen (BIIB) in Q4 2019, closing a stake of 1,400 shares — an estimated $326K sold.

Leap Investments first reported a position in BIIB in Q3 2019 and held it in 1 quarter. The position peaked at $326K in Q3 2019. 1,103 funds tracked by Wall St. Rank hold BIIB as of Q4 2019.

Leap Investments reported no remaining Biogen position as of Q4 2019 after selling out during the quarter.
Leap Investments sold 1,400 Biogen shares in Q4 2019, an estimated $326K.
Leap Investments first reported a position in Biogen in Q3 2019 and held it in 1 quarter.
Leap Investments's Biogen position peaked at $326K in Q3 2019.
1,103 funds tracked by Wall St. Rank held Biogen as of Q4 2019.

Based on Leap Investments's 13F filing for Q4 2019, filed 14 Feb 2020.